However, we also identified down-regulation of CASP4, CASP9 and IL6 in NASH patients and related to reduced risk of NASH, while these genes should also be involved in pyroptosis. This evidence concerns the gene CASP9 and metabolic dysfunction-associated steatohepatitis.